Diego Pellicer Worldwide (DPWW) 10-K 12 Apr 21 2020 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2020	Mar. 31, 2021	Jun. 30, 2020
Document And Entity Information
Entity Registrant Name	DIEGO PELLICER WORLDWIDE, INC
Entity Central Index Key	0001559172
Document Type	10-K
Document Period End Date	Dec. 31, 2020
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filer	No
Entity Filer Category	Non-accelerated Filer
Entity's Reporting Status Current	Yes
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Shell Company	false
Entity File Number	333-189731
Entity Interactive Data Current	Yes
Entity Incorporation, State or Country Code	DE
Entity Common Stock, Shares Outstanding		222,327,908
Entity Public Float			$ 1,730,402
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2020

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Current assets:
Cash	$ 327,864	$ 317,446
Accounts receivable	523,958	391,273
Prepaid expenses	11,275	12,111
Total current assets	863,097	720,830
Other receivables	1,030,422	788,177
Security deposits	90,000	150,000
Right of Use Assets	1,062,592	3,009,163
Total assets	3,046,111	4,668,170
Current liabilities:
Accounts payable	526,377	514,196
Accrued payable - related parties	1,332,756	1,293,238
Accrued expenses	931,825	587,707
Notes payable - related party	140,958	140,958
Notes payable	133,403	133,403
Convertible notes, net of discount and costs	3,239,274	2,352,530
Derivative liabilities	5,997,865	5,024,321
Lease Liabilities	327,685	676,336
Warrant liabilities	476	967
Total current liabilities	12,630,619	10,723,656
Notes payable - long term	206,444
Lease Liabilities, net of current portion	715,488	2,299,152
Total liabilities	13,552,551	13,022,808
Redeemable convertible preferred stock, Series C, par value $.00001 per share; 1,500,000 shares authorized, no shares and 140,000 shares issued and outstanding, net of discount of $0 and $131,250, respectively,		8,750
Deficiency in stockholders' equity:
Preferred stock, Series A and B, par value $.0001 per share; 5,000,000 shares authorized, none issued and outstanding
Common stock, par value $.000001 per share; 840,000,000 shares authorized, 217,271,495 and 113,926,332 shares issued and outstanding, respectively	216	114
Additional paid-in capital	44,554,119	43,478,139
Stock to be issued	49,225	127,261
Accumulated deficit	(55,110,000)	(51,968,902)
Total deficiency in stockholders' equity	(10,506,440)	(8,363,388)
Total liabilities and deficiency in stockholders' equity	$ 3,046,111	$ 4,668,170

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Common stock, par value	$ 0.000001	$ 0.000001
Common stock, shares authorized	840,000,000	840,000,000
Common stock, shares issued	217,271,495	113,926,332
Common stock, shares outstanding	217,271,495	113,926,332
Redeemable convertible preferred stock, Series C [Member]
Preferred stock, par value	$ .00001	$ .00001
Preferred stock, shares authorized	1,500,000	1,500,000
Preferred stock, shares issued	0	140,000
Preferred stock, shares outstanding	0	140,000
Discount	$ 0	$ 131,250
Series A Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Series B Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0

Consolidated Statements Of Oper

Consolidated Statements Of Operations - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Revenues
Net rental revenue	$ 1,265,137	$ 1,646,369
Rental expense	(1,006,581)	(1,189,352)
Gross profit	258,556	457,017
Operating expenses:
General and administrative expenses	1,029,185	2,521,649
Selling expense	32,940	52,605
Depreciation expense		139,595
Loss from Operations	(803,569)	(2,256,832)
Other income (expense)
Interest income	150,577	153,782
Other income	236,705
Interest expense	(1,994,199)	(3,184,951)
Lease termination payments	33,851
Gain on sale/termination of lease	55,256	534,649
Extinguishment of debt	(9,387)	218,196
Change in derivative liabilities	(670,152)	1,948,643
Change in value of warrants	491	15,609
Total other loss, net	(2,196,858)	(314,072)
Provision for taxes
Net loss	(3,000,427)	(2,570,904)
Accrued dividends and accretion of conversion feature
Deemed dividend on preferred stock	(140,671)	(43,968)
Net loss attributable to common stockholders	$ (3,141,098)	$ (2,614,872)
Loss per share - basic and diluted	$ (0.02)	$ (0.04)
Weighted average common shares outstanding - basic and diluted	150,896,077	59,828,096

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Deficit - USD ($)	Redeemable Convertible Preferred Stock	Common Stock	Preferred Stock	Additional Paid-In Capital	Accumulated Deficit	Common Stock to be issued	Total
Balance, beginning at Dec. 31, 2018		$ 28		$ 40,378,973	$ (49,354,030)	$ 710,838	$ (8,264,191)
Balance, beginning, shares at Dec. 31, 2018		28,287,414
Sale of common stock				2,648		(2,648)
Sale of common stock, shares		5,000
Issuance of common shares for services		$ 5		481,179		(310,836)	170,348
Issuance of common shares for services, shares		4,987,610
Issuance of common shares for services - related parties		$ 25		977,200		(245,196)	732,029
Issuance of common shares for services - related parties, shares		24,566,400
Common stock issued upon conversion of notes payable		$ 48		1,583,887		(133,018)	1,450,917
Common stock issued upon conversion of notes payable, shares		48,684,667
Shares cancelled for convertible note				(108,121)		108,121
Shares cancelled for convertible note, shares		(675,759)
Cashless warrant exercise		$ 8		$ (8)
Cashless warrant exercise (Shares)		8,071,000
Series C preferred stock issued for cash, net of costs and discounts
Series C preferred stock issued for cash, net of costs and discounts, shares	140,000
Accretion of conversion feature on Series C preferred stock	$ 8,750				$ (8,750)		$ (8,750)
Fair value of warrants and options granted for services				162,381			162,381
Deemed dividends related to conversion feature of Series C preferred stock					(35,218)		(35,218)
Net loss					(2,570,904)		(2,570,904)
Balance, ending at Dec. 31, 2019	$ 8,750	$ 114		43,478,139	(51,968,902)	127,261	(8,363,388)
Balance, ending, shares at Dec. 31, 2019	140,000	113,926,332
Issuance of common shares for services		$ 4		51,196		2,719	53,919
Issuance of common shares for services, shares		4,000,000
Issuance of common shares for services - related parties		$ 13		177,311		(66,772)	110,552
Issuance of common shares for services - related parties, shares		12,219,836
Common stock issued upon conversion of notes payable		$ 39		$ 328,847		$ (13,983)	$ 314,903
Common stock issued upon conversion of notes payable, shares		39,489,099
Series C preferred stock issued for cash, net of costs and discounts
Series C preferred stock issued for cash, net of costs and discounts, shares	111,600
Series C preferred stock converted to common stock	$ (89,295)	$ 46		$ 432,020			$ 432,066
Series C preferred stock converted to common stock, shares	(251,600)	47,636,228
Accretion of conversion feature on Series C preferred stock	$ 80,545				(80,545)		(80,545)
Fair value of warrants and options granted for services				86,606			86,606
Deemed dividends related to conversion feature of Series C preferred stock					(60,126)		(60,126)
Net loss					(3,000,427)		(3,000,427)
Balance, ending at Dec. 31, 2020		$ 216		$ 44,554,119	$ (55,110,000)	$ 49,225	$ (10,506,440)
Balance, ending, shares at Dec. 31, 2020		217,271,495

Consolidated Statement Of Cash

Consolidated Statement Of Cash Flow - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net loss	$ (3,000,427)	$ (2,570,904)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation		139,595
Change in fair value of derivative liability	670,152	(1,948,643)
Change in value of warrants	(491)	(15,609)
Amortization of debt related costs	942,601	2,833,612
Noncash finance cost	100,000
Expense related to additional derivative liability	584,553
Extinguishment of debt	9,387	(218,196)
Stock based compensation	192,475	1,014,756
Common stock payable issued for services	44,619
Gain on sale/termination of lease	(55,256)	(534,649)
Changes in operating assets and liabilities:
Accounts receivable	(132,685)	(222,414)
Prepaid expenses	836	42,059
Other assets	(242,243)	(463,416)
Security deposits	60,000
Accounts payable	12,181	(98,385)
Accrued liability - related parties	39,518	879,132
Accrued expenses	358,820	294,217
Lease liabilities	69,512	(107,236)
Contingent liabilities		(207,910)
Cash used by operating activities	(346,448)	(1,183,991)
Cash flows from investing activities:
Proceeds from sale of lease		550,000
Cash flows from investing activities		550,000
Cash flows from financing activities:
Debt costs		(16,225)
Proceeds from notes payable	206,444
Net proceeds from convertible notes payable	100,000	897,725
Repayments of convertible notes payable, net	(49,578)	(120,500)
Proceeds from sale of preferred stock, net	100,000	130,000
Cash provided by financing activities	356,866	891,000
Net increase in cash	10,418	257,009
Cash, beginning of year	317,446	60,437
Cash, end of year	327,864	317,446
Cash paid for interest
Cash paid for taxes
Supplemental schedule of noncash financial activities:
Lease liability related to termination of lease	1,325,445
Notes converted to stock	180,922	842,712
Discount related to convertible notes and convertible Preferred C shares	214,600	905,500
Accrued interest converted to stock	14,702	60,627
Value of derivative liability extinguished upon conversion of notes and preferred stock and payment of notes	530,042	891,922
Accounts payable and accrued expenses paid with common stock		50,000
Debt issuance costs deducted from proceeds of notes		16,225
Debt discount extinguished with note conversion	53,567
Debt discount extinguished with note repayment	21,075
Conversion of preferred stock to common stock	265,115
Discount extinguished with preferred stock conversion	175,820
Accrued dividends and accretion of conversion feature	80,545
Deemed dividends related to conversion feature of Series C preferred stock	$ 60,126

Organization and Operations

Organization and Operations	12 Months Ended
	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Operations	Note 1 – Organization and Operations History On March 13, 2015, Diego Pellicer Worldwide, Inc. (the Company) (f/k/a Type 1 Media, Inc.) closed on a merger and share exchange agreement by and among (i) the Company, and (ii) Diego Pellicer World-wide 1, Inc., a Delaware corporation, (“Diego”), and (iii) Jonathan White, the majority shareholder of the Company. Diego was merged with and into the Company with the Company to continue as the surviving corporation in the merger. Business Operations The Company leases real estate to licensed marijuana operators, providing complete turnkey growing space, processing space, recreational and medical retail sales space and related facilities to licensed marijuana growers, processors, dispensary and recreational store operators. Additionally, the Company plans to explore ancillary opportunities in the regulated marijuana industry, as well as offering for wholesale distribution branded non-marijuana clothing and accessories. The properties generating rents in 2020 and 2019 are as follows: Purpose Size City State Retail store (recreational and medical) 3,300 sq. Denver CO Cultivation warehouse – terminated October 2020 18,600 sq. Denver CO Cultivation warehouse 14,800 sq. Denver CO Retail store (recreational and medical) – sold in May 2019 4,500 sq. Seattle WA The Company’s three properties in Denver, CO (one terminated in October 2020) are leased to Royal Asset Management, LLC (“RAM”). RAM opened the Diego Denver branded flagship store in February 2017. This store is known as “Diego Colorado”. The retail facilities have shown steady growth in sales since opening. For the other two properties subleased (one terminated in October 2020), RAM uses these properties for its cultivation facilities in Denver, CO. Production at these facilities began in late 2016. The Company is currently exploring the acquisition of this entity, and the parties are in negotiations (see Note 5). In regards to the Seattle property, on May 6, 2019 the Company entered into an agreement with a third party, and sold the Seattle leased location. The sale provided $550,000 in capital and executive resources for possible expansion and working capital purposes. In October 2020, the master lease and sublease associated with the 18,600 sq. cultivation warehouse in Denver were terminated (see Note 5).

Significant and Critical Accoun

Significant and Critical Accounting Policies and Practices	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Significant and Critical Accounting Policies and Practices	Note 2 – Significant and Critical Accounting Policies and Practices The management of the Company is responsible for the selection and use of appropriate accounting policies and for the appropriateness of accounting policies and their application. Critical accounting policies and practices are those that are both most important to the portrayal of the Company’s financial condition and results of operations and that require management’s most difficult, subjective, or complex judgments, often because of the need to make estimates about the effects of matters that are inherently uncertain. The Company’s significant and critical accounting policies and practices are disclosed below, as required by generally accepted accounting principles. Basis of Presentation The accompanying consolidated financial statements and related notes have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and presented in accordance with accounting principles generally accepted in the United States of America (US GAAP). Principles of Consolidation The financial statements include the accounts of Diego Pellicer Worldwide, Inc., and its wholly-owned subsidiary Diego Pellicer World-wide 1, Inc. Intercompany balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates. These estimates and assumptions include valuing equity securities and derivative financial instruments issued in financing transactions and share based payment arrangements, the collectability of accounts receivable and other receivables (See Note 5), valuation of right of use assets and lease liabilities and deferred taxes and related valuation allowances. Certain estimates, including evaluating the collectability of accounts receivable, could be affected by external conditions, including those unique to our industry, and general economic conditions. It is possible that these external factors could influence our estimates and could cause actual results to differ from our estimates. The Company intends to re-evaluate all its accounting estimates at least quarterly based on these conditions and record adjustments when necessary. Fair Value Measurements The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. Fair Value of Financial Instruments As required by the Fair Value Measurements and Disclosures Topic of the FASB ASC, fair value is measured based on a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2: Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; and Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity). Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of December 31, 2020 and December 31, 2019. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values. These financial instruments include cash, prepaid expenses and accounts payable. Fair values were assumed to approximate carrying values for cash and payables because they are short term in nature and their carrying amounts approximate fair values or they are payable on demand. The following table reflects assets and liabilities that are measured at fair value on a recurring basis (in thousands): As of December 31, 2020 Fair Value Measurement Using Level 1 Level 2 Level 3 Total Derivative liabilities $ — $ — $ 5,998 $ 5,998 Stock warrant liabilities — — 1 1 $ — $ — $ 5,999 $ 5,999 As of December 31, 2019 Fair Value Measurement Using Level 1 Level 2 Level 3 Total Derivative Liabilities $ — $ — $ 5,024 $ 5,024 Stock warrant Liabilities — — 1 1 $ — $ — $ 5,025 $ 5,025 Derivative liabilities and stock warrant liabilities were valued using the Binomial Option Pricing Model in calculating the embedded conversion features for the years ended December 31, 2020 and 2019. Cash The Company maintains cash balances at various financial institutions. Accounts at each institution are insured by the Federal Deposit Insurance Corporation, and the National Credit Union Share Insurance Fund, up to $250,000. The Company’s accounts at these institutions may, at times, exceed the federal insured limits. The Company has not experienced any losses in such accounts. Uninsured balances were approximately $73,000 and $63,000 at December 31, 2020 and 2019, respectively. Revenue recognition In accordance with ASC 842, Leases, During the initial term of the lease, management has a policy of partial rent forbearance when the tenant first opens the facility to assure that the tenant has the opportunity for success. Management may be required to exercise considerable judgment in estimating revenue to be recognized. When management concludes that the Company is the owner of tenant improvements, the Company records the cost to construct the tenant improvements as a capital asset. In addition, the Company records the cost of certain tenant improvements paid for or reimbursed by tenants as capital assets when management concludes that the Company is the owner of such tenant improvements. For these tenant improvements, the Company records the amount funded or reimbursed by tenants as deferred revenue, which is amortized as additional rental income over the term of the related lease. When management concludes that the tenant is the owner of tenant improvements for accounting purposes, we record the Company’s contribution towards those improvements as a lease incentive, which is amortized as a reduction to rental revenue on a straight-line basis over the term of the lease. The Company has adopted the new revenue recognition guidelines in accordance with ASC 606, Revenue from Contracts with Customers (ASC 606), commencing from January 1, 2019. The adoption of ASC 606 did not have a material impact on the financial statements and related disclosures since the Company is primarily a lessor for revenue purposes and recognizes rent income under ASC 842, Leases The Company analyzes its contracts to assess that they are within the scope and in accordance with ASC 606. In determining the appropriate amount of revenue to be recognized as the Company fulfills its obligations under each of its agreements, whether for goods and services or licensing, the Company performs the following steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations based on estimated selling prices; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. Advertising During the years ended December 31, 2020 and 2019, advertising expense was $32,940 and $52,605, respectively. Income Taxes Income taxes are provided for using the liability method of accounting in accordance with the Income Taxes Topic of the FASB ASC. Deferred tax assets and liabilities are determined based on differences between the financial reporting and tax basis of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is established when necessary to reduce deferred tax assets to the amount expected to be realized and when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The computation of limitations relating to the amount of such tax assets, and the determination of appropriate valuation allowances relating to the realizing of such assets, are inherently complex and require the exercise of judgment. As additional information becomes available, the Company continually assesses the carrying value of their net deferred tax assets. Common Stock Purchase Warrants and Other Derivative Financial Instruments The Company classifies as equity any contracts that require physical settlement or net-share settlement or provide us a choice of net cash settlement or settlement in our own shares (physical settlement or net-share settlement) provided that such contracts are indexed to our own stock as defined in ASC Topic 815-40 “Contracts in Entity’s Own Equity.” The Company classifies as assets or liabilities any contracts that require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside our control or give the counterparty a choice of net-cash settlement or settlement in shares. The Company assesses classification of its common stock purchase warrants and other free-standing derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required. Stock-Based Compensation The Company recognizes compensation expense for stock-based compensation in accordance with ASC Topic 718. The Company calculates the fair value of the award on the date of grant using the Black-Scholes method for stock options and the quoted price of our common stock for common shares; the expense is recognized over the service period for awards expected to vest. The estimation of stock-based awards that will ultimately vest requires judgment, and to the extent actual results or updated estimates differ from original estimates, such amounts are recorded as a cumulative adjustment in the period estimates are revised. The Company considers many factors when estimating expected forfeitures, including types of awards, employee class, and historical experience. Income (loss) per common share The Company utilizes ASC 260, “Earnings per Share” for calculating the basic and diluted loss per share. In accordance with ASC 260, the basic and diluted loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding. Diluted net loss per share is computed similar to basic loss per share except that the denominator is adjusted for the potential dilution that could occur if stock options, warrants, and other convertible securities were exercised or converted into common stock. Potentially dilutive securities are not included in the calculation of the diluted loss per share if their effect would be anti-dilutive. The Company has 1,462,069,888 and 631,737,597 common stock equivalents at December 31, 2020 and 2019, respectively. For the years ended December 31, 2020 and 2019, these potential shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would reduce net loss per share. There are 840,000,000 shares authorized resulting in 839,341,383 insufficient shares as of December 31, 2020. Legal and regulatory environment The cannabis industry is subject to numerous laws and regulations of federal, state and local governments. These laws and regulations include, but are not limited to, matters such as licensure, accreditation, and different taxation between federal and state. Federal government activity may increase in the future with respect to companies involved in the cannabis industry concerning possible violations of federal statutes and regulations. Management believes that the Company is in compliance with local, state and federal regulations and, while no regulatory inquiries have been made, compliance with such laws and regulations can be subject to future government review and interpretation, as well as regulatory actions unknown or unasserted at this time. Recent accounting pronouncements. The Company believes recently issued accounting pronouncements and other authoritative guidance for which the effective date is in the future either will not have an impact on its accounting or reporting or that such impact will not be material to its financial position, results of operations and cash flows when implemented.

Going Concern

Going Concern	12 Months Ended
	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	Note 3 – Going Concern The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has incurred losses since inception, its current liabilities exceed its current assets by $11,767,522 at December 31, 2020, and it has an accumulated deficit of $55,110,000 at December 31, 2020. These factors raise substantial doubt about its ability to continue as a going concern over the next twelve months. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. The Company believes that it has sufficient cash on hand and cash generated by real estate leases to sustain operations provided that management and board members continue to agree to be paid company stock in exchange for accrued compensation. There are other future noncash charges in connection with financings such as a change in derivative liability that will affect income but have no effect on cash flow. Although the Company has been successful raising additional capital, there is no assurance that the company will sell additional shares of stock or borrow additional funds. The Company’s inability to raise additional cash could have a material adverse effect on its financial position, results of operations, and its ability to continue in existence. These financial statements do not include any adjustments that might result from the outcome of this uncertainty. Management believes that the Company’s future success is dependent upon its ability to achieve profitable operations, generate cash from operating activities and obtain additional financing. There is no assurance that the Company will be able to generate sufficient cash from operations, sell additional shares of stock or borrow additional funds. However, cash generated from lease revenues is currently exceeding lease costs, but is insufficient to cover operating expenses.

Property and Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2020
Property, Plant and Equipment [Abstract]
Property and Equipment	Note 4 – Property and Equipment On May 6, 2019, the Company entered into an agreement with a third party, by which the Company sold the Seattle leased location for $550,000 in cash. The Company plans to allocate its efforts to new locations and cannabis grow facilities in Colorado. In connection with the sale, fully amortized leasehold improvements with a historical cost of $566,830 were sold. During the years ended December 31, 2020 and 2019, the Company recorded depreciation expense of $0 and $139,595, respectively. The Company’s assets were fully depreciated at December 31, 2020 and 2019.

Accounts Receivables and Other

Accounts Receivables and Other Receivables	12 Months Ended
	Dec. 31, 2020
Common shares issued for security payment of convertible notes, value
Accounts Receivables and Other Receivables	Note 5 – Accounts Receivables and Other Receivables As disclosed in Note 1, the Company subleases three properties in Colorado to Royal Asset Management. At December 31, 2020 and 2019, the Company had outstanding receivables from the subleases totaling $523,958 and $391,273, respectively, and during 2020 and 2019 the Company’s subleases with RAM accounted for 100% and 93% of the Company’s revenues, respectively. In addition to the receivables from the subleases, the Company has agreed to provide RAM and affiliates of RAM up to an aggregate amount of $1,030,000 in financing. These notes accrue interest at the rates ranging from 12% to 18% per annum. As of December 31, 2020 and 2019, the outstanding balance of these notes receivable total $1,030,422 and $788,177, respectively, including accrued interest of $300,422 and $153,509, respectively. The amount presented in our balance sheet at December 31, 2019 is $788,177, which represents $1,017,143 due to us, less $228,966 that we owed to RAM for leasehold improvements. At December 31, 2020 it was determined that we did not owe the $228,966 amount to RAM for the improvements, and we included the increase in the notes balance as Other Income in the consolidated financial statements for the year ended December 31, 2020. The notes are secured by a UCC filing and also $400,000 of the balance is personally guaranteed by the managing member of RAM. Our position is subordinate to the CEO’s note described in Note 7. We have recorded interest income of $146,913 and $153,509 during the years ended December 31, 2020 and 2019, respectively. If we do consummate any agreement to acquire Royal Asset Management, part of the purchase price will be paid through receivables that are owed to us (see below). On September 9, 2020, we closed on a Membership Interest Purchase Agreement dated September 4, 2020, and obtained the right to acquire a 15.13% membership interest in Blue Bronco, LLC. The purchase of the 15.13% interest in Blue Bronco LLC is subject to the approval of the Colorado Marijuana Enforcement Division. Necessary approval by governing authorities is expected to be received in the second quarter of 2021. As part of these transactions, we received full payment of a promissory note receivable in the principal amount of $300,000, as well as full payment of an outstanding promissory note receivable, dated February 27, 2020, in the principal amount of $50,000. Upon receipt of this payment of $50,000, we made a payment of $34,265 in order to “true up” our obligations under that certain promissory note, dated July 25, 2019, in the principal amount of $400,000 made in favor of the Company. Additionally, accrued interest receivable under the $300,000 note of approximately $68,000 will be applied to the purchase of the membership interest upon approval of the purchase by the Colorado Marijuana Enforcement Division. During the year ended December 31, 2020 we made additional advances under the note aggregating $254,448 and we received payments on the notes aggregating $388,082. These amounts include those transactions discussed in the preceding paragraph. Lease Termination On October 1, 2020, the master and sublease associated with the 18,600 sq. cultivation warehouse in Denver were terminated. In connection with that termination, we entered into a Sublease Termination Agreement (“Termination Agreement”) with RAM and an affiliate of RAM Venture Product Consulting, LLC (“VPC”). Pursuant to this agreement, RAM acknowledged a debt of deferred rent to the Company in the amount of $1,418,480 and VPC acknowledged a debt of deferred rent to the Company in the amount of $64,344. RAM and VPC executed promissory notes for these amounts, respectively. The notes accrue interest on the unpaid balance at a rate equal to the Applicable Federal Rate for mid-term obligations as published by the Internal Revenue Service. No payment under the promissory notes will be due to the Company until the earlier of (i) the date on which RAM and the Company consummate a change of control event, which is defined as: the acquisition of RAM by the Company or an affiliated entity by means of any transaction or series of related transactions to which RAM is a party (including, without limitation, any membership interest acquisition, reorganization, merger or consolidation, (generally, a “Merger”), or, (ii) the date one (1) business day following the earlier of (x) at any time, receipt by the Company from RAM or VPC of a written notice stating such party no longer desires to pursue the Merger, or (y) beginning eighteen (18) months after the date of this Agreement, receipt by RAM or VPC from The Company of a written notice stating that the Company no longer desires to pursue the Merger (the “Maturity Date”). We have recorded the promissory notes as long term notes receivable of $1,482,824 at December 31, 2020. Due to the uncertainty of the collectability, we have also recorded a long term deferred credit in the same amount. We will record income under the deferred rent notes as payments are received or deemed collectible. This asset and related credit have been netted on the accompanying consolidated balance sheet. Additionally, in connection with the termination of the sublease, RAM will continue to pay the remaining future sublease premium payments due to the company on the Denver sublease (the “Future Rent Debt”) beginning on the termination date, and until the earlier of the Maturity Date or June 30, 2024, notwithstanding the termination of the Subleases. However, no payment under the Future Rent Debt agreement will be due to the Company until the Maturity Date, at which time the entire Future Rent Debt shall be due and payable in full, except for any month in which RAM earns $725,000 of gross sales revenue, including taxes, at its Alameda location, in which case RAM shall pay the Future Rent Debt for the following month to the Company on or before the 5th day of the following month, and such amount will not accrue as a Future Rent Debt. RAM shall continue to accrue debt to the company, assessed on the first day of each month, according to the schedule below: Monthly Payments Accrued October 1, 2020 to June 30, 2021 $ 11,284 July 1, 2021 to June 30, 2022 11,622 July 1, 2022 to June 30, 2023 11,971 July 1, 2023 to June 30, 2024 12,330 We will record income pursuant to the Future Rent Debt as payments are received based on the Company’s analysis of collectability including, but not limited to, the potential application toward the purchase price. During 2020, we received three months of payments and have recorded $33,851 as Lease Termination Payments in the Statement of Operations.

Other Assets

Other Assets	12 Months Ended
	Dec. 31, 2020
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Other Assets	Note 6 – Other Assets Security deposits:

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2020
Related Party Transactions [Abstract]
Related Party Transactions	Note 7 – Related Party Transactions As of December 31, 2020 and 2019, the Company has accrued compensation to its CEO and director and to its CFO aggregating $289,897 and $155,841, respectively. As of December 31, 2020 and 2019, accrued payable due to former officers was $1,042,859 and $1,137,397, respectively. For the years ended December 31, 2020 and 2019, total cash-based compensation to related parties was $360,000 and $507,430, respectively. For the years ended December 31, 2020 and 2019, total share-based compensation to related parties was $192,474 and $894,408, respectively. These amounts are included in general and administrative expenses in the accompanying financial statements. From 2017 to 2019, Mr. Gonfiantini, CEO, personally and through his Company, Crystal Bay Financial LLC, loaned an aggregate amount of $1,020,000 to Royal Asset Management. These notes accrue interest at 17%-18% per annum, and require monthly payment approximately from $5,000 to $20,000. These notes are personally guaranteed by the managing member of Royal Asset Management, and are secured by certain equipment and other tangible properties of Royal Asset Management. Among these notes, $500,000 note was also secured by the medical marijuana licenses held by Royal Asset Management. At December 31, 2020 and 2019, the Company owed Mr. Throgmartin, former CEO (See Note 11), $140,958 pursuant to a promissory note dated August 12, 2016. This note accrues interest at the rate of 8% per annum and was past the maturity date, however the Company has not yet received a default notice. The balance of related party note was $140,958 at December 31, 2020 and December 31, 2019 and accrued interest on the note was $49,401 and $38,124 at December 31, 2020 and 2019, respectively.

Notes Payable

Notes Payable	12 Months Ended
	Dec. 31, 2020
Notes Payable [Abstract]
Notes Payable	Note 8 – Notes Payable On August 31, 2015, the Company issued a note in the amount of $126,000 to a third party for use as operating capital. The note was amended to include accrued interest on October 31, 2016 and extend the maturity date to October 31, 2018. As of December 31, 2020 and 2019 the outstanding principal balance of the note was $133,403, and accrued interest on the note was $70,101 and $63,413 at December 31, 2020 and 2019, respectively. As of December 31, 2020 the note was past the maturity date, however the Company has not yet received a default notice. On April 22, 2020, the Company was granted a loan from Numerica Credit Union, in the aggregate amount of $56,444, pursuant to the Paycheck Protection Program, (the “PPP”) under Division A, Title I of the CARES Act, which was enacted March 27, 2020. The loan, which was in the form of a note dated April 22, 2020 issued by the Borrower, matures on April 22, 2022 and bears interest at a rate of 1.0% per annum, payable monthly commencing October 22, 2020. There have not been any payments made towards this loan, as the full amount of the loan expects to be forgiven when the company applies for forgiveness. Application for loan forgiveness is due ten months from the last day of the twenty-four week window that the company has to spend the money from the disbursement date of the loan on April 22, 2020. The loan may be prepaid by the Borrower at any time prior to maturity with no prepayment penalty. Funds from the Loan may only be used for payroll costs, costs used to continue group health care benefits, mortgage payments, rent, utilities, and interest on other debt obligations incurred before February 15, 2020. The Company used the entire Loan amount for qualifying expenses. Under the terms of the PPP, certain amounts of the Loan may be forgiven if they are used for qualifying expenses as described in the CARES Act. The PPP loan was fully forgiven in February 2021. On June 30, 2020, the Company was granted a loan from the Small Business Association, in the aggregate amount of $150,000, pursuant to the Economic Injury Disaster Loan, (the “EIDL”) under Division A, Title I of the CARES Act. The Company received the net funds of $149,900 on July 2, 2020. The loan, which is in the form of a note dated June 30, 2020 issued by the Borrower, matures on June 30, 2050 and bears interest at a rate of 3.75% per annum, payable monthly commencing June 30, 2021. The loan may be prepaid by the Borrower at any time prior to maturity with no prepayment penalty. Funds from the Loan may be used solely for working capital to alleviate economic injury caused by disaster occurring in the month of January 31, 2020 and continuing thereafter and to pay Uniform Commercial Code (UCC) lien filing fees and a third-party UCC handling charge of $100 which was deducted from the loan amount stated above. The Company used the entire Loan amount for qualifying expenses.

Convertible Notes Payable

Convertible Notes Payable	12 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Convertible Notes Payable	Note 9 – Convertible Notes Payable The Company has issued several convertible notes which are outstanding. The note holders have the right to convert principal and accrued interest outstanding into shares of common stock at a discounted price to the market price of our common stock. The conversion features were recognized as embedded derivatives and are valued using a Binomial Option Pricing Model that resulted in a derivative liability of $5,997,865 and $4,834,190 at December 31, 2020 and 2019, respectively. All notes accrue interest at rates ranging from 8% to 12% and the majority of the notes had matured at December 31, 2020. In connection with the issuance of certain of these notes, the Company also issued warrants to purchase its common stock. Several convertible note holders elected to convert their notes to stock during the years ended December 31, 2020 and 2019. The table below provides the note payable activity for the years ended December 31, 2020 and 2019, and also a reconciliation of the beginning and ending balances for the derivative liabilities measured using fair significant unobservable inputs (Level 3) for the years ended December 31, 2020 and 2019: Convertible Discount Convertible Derivative Balance, December 31, 2019 $ 3,266,775 $ 914,245 $ 2,352,530 $ 4,834,190 Issuance of convertible notes 103,000 103,000 — 518,678 Extensions of convertible notes 100,000 — 100,000 149,500 Conversion of convertible notes (180,922 ) (53,567 ) (127,355 ) (177,037 ) Repayment of convertible notes (49,579 ) (21,075 ) (28,504 ) (28,930 ) Change in fair value of derivatives — — — 701,464 Amortization — (942,603 ) 942,603 — Balance December 31, 2020 $ 3,239,274 $ — $ 3,239,274 $ 5,997,865 Convertible Discount Convertible Derivative Balance, December 31, 2018 $ 3,324,487 $ 2,151,168 $ 1,173,319 $ 6,000,830 Issuance of convertible notes 905,500 905,500 — 1,803,495 Conversion of convertible notes (842,712 ) (233,571 ) (609,141 ) (940,382 ) Repayment of convertible notes (120,500 ) (3,659 ) (116,841 ) (56,197 ) Change in fair value of derivatives — — — (1,973,556 ) Amortization — (1,905,193 ) 1,905,193 — Balance December 31, 2019 $ 3,266,775 $ 914,245 $ 2,352,530 $ 4,834,190 During 2020, the Company entered into a convertible note in an aggregate amount of $103,000 with a twelve month maturity, bearing 12% interest per year. The note is convertible at a 35% discount to the average of the two lowest Volume Weighted Average Prices (VWAPs) during the previous ten trading days to the date of a Conversion Notice. This note was partially converted to common stock in the amount of $60,922 during 2020 along with accrued interest in the amount of $1,884, for a total of 14,079,305 shares issued upon conversion, with a value of $98,080. A loss on extinguishment of debt of $11,761, extinguishment of debt discount of $28,190 and reduction of derivative liabilities of $51,703 have been recorded related to the conversion. The remaining balance on this convertible loan of $42,078 was paid in cash along with accrued interest in the amount of $6,736. A loss on extinguishment of debt of $21,460, extinguishment of debt discount of $21,075 and reduction of derivative liabilities of $18,551 have been recorded related to the payment of $67,750. During 2020, an additional $120,000 of notes and $12,818 of accrued interest and fees was converted into 25,409,794 shares of common stock with a value of $230,807. A gain on extinguishment of debt of $1,968, extinguishment of debt discount of $25,377 and reduction of derivative liabilities of $125,334 have been recorded related to these conversions. During 2020, an additional $7,500 of note principal and $819 of accrued interest were repaid to debt holders. We recorded gain on extinguishment of debt of $3,925. During 2020, we recorded noncash additions to convertible notes aggregating $100,000 as a result of extensions to the maturity dates. As of December 31, 2020, convertible notes in the aggregate principal amount of $2,839,274 were past their maturity dates; however the Company has not yet received any default notices. No default or penalty was paid or required to be paid. During the year ended December 31, 2019, the Company entered into several convertible notes in an aggregate amount of $905,500, bearing interest ranging from 10% to 12% per annum. During the year ended December 31, 2019, $120,500 of notes principal and $14,195 of accrued interest were repaid to a debt holder. During the year ended December 31, 2019, $842,712 of notes and $60,627 of accrued interest was converted into 48,684,667 shares of common stock and 434,783 shares were issued which had been authorized as of December 31, 2018. A gain on extinguishment of debt of $159,233, extinguishment of debt discount of $233,571 and reduction of derivative liabilities of $940,382 have been recorded related to these conversions. On July 17, 2018, the Company entered into a certain Equity and Debt Restructure Agreement with two long-time investors in the Company (the “Restructure Agreement”). Pursuant to the material terms of the Restructure Agreement, the investors agreed to return and cancel their collective 2,774,093 restricted Company common shares, which had been received from the prior conversion of their older convertible notes, in exchange for the Company’s issue to them of recast convertible promissory notes. Accordingly, on the same date, these investors were each issued a First Priority Secured Promissory Note (the “Note” or “Notes”), in the principal amount of $1,683,558 and $545,607, respectively. In connection with this transaction, one of these investors agreed to loan the Company an additional $700,000. In 2018, the Company received $220,000 cash proceeds of the additional $700,000 loan. Fair value of the 2,774,093 restricted Company common shares was determined to be $443,855 using market price and the fair value of the embedded conversion feature was determined to be $3,555,888 using Black Sholes Option Model. As a result of the transaction, the Company recorded $2,892,033 in financing costs and $2,449,275 as debt discount during year ended December 31, 2018. On March 29, 2019, the Company received $100,000 cash proceeds from the additional $700,000 loan. The conversion feature related to $100,000 was determined to be $154,861 using the Binomial Option Pricing Model. During year ended December 31, 2019, the Company received $380,000 cash proceeds from the additional $700,000 loan. The conversion feature related to $380,000 was determined to be $586,710 using the Binomial Option Pricing Model. During the year ended December 31, 2019, we recorded $206,710 of expense related to financing costs and $380,000 as debt discount. The following assumptions were used in the Binomial Option Pricing Model in calculating the embedded conversion features and current liabilities for the years ended December 31, 2020 and 2019: December 31, December 31, Risk-free interest rates 0.08 % 1.53 – 2.60 % Expected life (years) 0.25 0.08 – 1.25 Expected dividends 0 % 0 % Expected volatility 164 % 70-557 %

Stockholder's Equity (Deficit)

Stockholder's Equity (Deficit)	12 Months Ended
	Dec. 31, 2020
Equity [Abstract]
Stockholder's Equity (Deficit)	Note 10 – Stockholders’ Equity (Deficit) Series C Preferred Stock On December 16, 2019, the Company sold 140,000 of its Series C Convertible Preferred Shares, with an annual accruing dividend of 10%, to Geneva Roth Remark Holdings, Inc. (“Geneva”), for $130,000 pursuant to a Series C Preferred Purchase Agreement with Geneva. To accommodate this transaction, The Company’s Board of Directors approved and filed a certain Certificate of Designations with the Secretary of State of Delaware, designating 1,500,000 of its available preferred shares as Series C Preferred Convertible Stock, Stated Value of $1.00 per share, and with a par value of $0.0001 per share. This Certificate of Designation provides the Company with the opportunity to redeem the Series C Shares at various increased prices at time intervals up to the 6-month anniversary of the closing and mandates full redemption on the 24-month anniversary. Geneva may convert the Series C Shares into our common shares, commencing on the 6-month anniversary of the closing at a 30% discount to the public market price. The Company recorded a derivative liability associated with Series C Preferred Shares of $165,218, valued using a Binomial Option Pricing Model. On December 31, 2019, the fair value of the conversion feature associated with Series C Preferred Shares was a derivative liability of $190,131, valued using a Binomial Option Pricing Model. The Series C Preferred Stock is classified as temporary equity due to the fact that the shares are immediately convertible at the option of the note holder. During the year ended December 31, 2019, we recorded $8,750 accretion of discount. As of December 31, 2019, there were 140,000 shares outstanding and a discount of $131,250. For the year ended December 31, 2020, the holders converted 140,000 shares of series C preferred stock along with related discount into 21,744,479 shares of common stock per the terms of the Agreement. As of December 31, 2020, there were no shares outstanding related to this issuance. On March 3, 2020, the Company sold 55,800 of its Series C Convertible Preferred Shares, with an annual accruing dividend of 10%, to Geneva for $50,000, pursuant to a Series C Preferred Purchase Agreement with Geneva. The Company recorded a derivative liability associated with Series C Preferred Shares of $88,868, valued using a Binomial Option Pricing Model. During the year ended December 31, 2020, the holder converted 55,800 shares of series C preferred stock along with related discount into 10,598,864 shares of common stock per the terms of the Agreement. As of December 31, 2020, there were no shares outstanding related to this issuance. The Series C Preferred Stock was classified as temporary equity due to that the shares are immediately convertible at the option of the note holder. On April 14, 2020, the Company sold 55,800 of its Series C Convertible Preferred Shares, with an annual accruing dividend of 10%, to Geneva for $50,000, pursuant to a Series C Preferred Purchase Agreement with Geneva. The Company recorded a derivative liability associated with Series C Preferred Shares of $82,028 valued using a Binomial Option Pricing Model. During the year ended December 31, 2020, the holder converted 55,800 shares of series C preferred stock along with related discount into 15,292,885 shares of common stock per the terms of the Agreement. As of December 31, 2020, there were no shares outstanding related to this issuance. The Series C Preferred Stock was classified as temporary equity due to that the shares are immediately convertible at the option of the note holder. Preferred Discount Preferred Derivative Balance , January 1, 2019 $ — — — — Issuance of Series C Preferred shares 140,000 140,000 — 165,218 Accretion of discount — (8,750 ) 8,750 — Change in fair value of derivatives — — — 24,913 Balance, December 31, 2019 140,000 131,250 8,750 190,131 Issuance of Series C Preferred shares 111,600 111,600 — 170,896 Conversion of Series C Preferred shares and accrued dividend (265,115 ) (175,820 ) (89,295 ) (353,005 ) Accretion of conversion feature on Series C preferred stock 13,515 (67,030 ) 80,545 23,290 Change in fair value of derivatives — — — (31,312 ) Balance December 31, 2020 $ — $ — $ — $ — The following assumptions were used in the Binomial Option Pricing Model in calculating the embedded conversion features and current liabilities for the years ended December 31, 2020 and 2019: 2020 2019 Risk-free interest rates 0.11 – 0.23% 1.58 – 1.66% Expected life (years) 1.5 – 2.0 1.95 – 2.0 Expected dividends 0% 0% Expected volatility 172 – 262% 248 - 250% Common Stock 2020 Transactions During the year ended December 31, 2020, $180,922 of notes and $14,702 of accrued interest and fees were converted into 39,489,099 shares of common stock with a value of $328,887. A loss on extinguishment of debt of $5,835, extinguishment of debt discount of $53,567 and reduction of derivative liabilities of $180,995 have been recorded related to these conversions. During the year ended December 31, 2020, 10,935,040 shares of common stock, valued at $117,887, were accrued for related party services. We issued 12,219,836 shares of common stock, valued at $177,323 during 2020, and these shares have been removed from shares to be issued at December 31, 2020. Additionally, we reversed the over accrual of 283,182 common shares, valued at $6,914, and reduced shares to be issued at December 31, 2020. At December 31, 2020 and 2019, shares to be issued for related party services were 1,731,687 and 3,299,665, respectively, and the value of shares to be issued at December 31, 2020 and 2019 was $13,467 and $79,817, respectively. During the year ended December 31, 2020, 905,658 shares of common stock, valued at $8,003, were accrued for services. We issued no shares during 2020 for this accrual. We reversed the over accrual of 9,583 common shares, valued at $5,601 and reduced shares to be issued at December 31, 2020. At December 31, 2020 and 2019, shares to be issued for services were 1,105,857 and 209,782, respectively, and the value of shares to be issued at December 31, 2020 and 2019 was $14,000 and $11,598, respectively. During the year ended December 31, 2020, we reversed the over accrual of 3,884 common shares, valued at $13,983, related to notes payable that were converted in prior years, and reduced shares to be issued at December 31, 2020. We recorded the reversal of the value of the shares as gain on extinguishment of debt. At December 31, 2020 and 2019, shares to be issued for debt conversions were 31,960 and 35,844, respectively, and the value of shares to be issued at December 31, 2020 and 2019 was $21,861 and $35,844, respectively. During the year ended December 31, 2020, we issued 4,000,000 shares of common stock, valued at $51,200, for legal services. During the year ended December 31, 2020, 47,636,228 shares of common stock were issued as a result of the conversion of 251,600 shares of Series C Preferred shares. 2019 Transactions During the year ended December 31, 2019, $842,712 of notes and $60,627 of accrued interest was converted into 48,684,667 shares of common stock and 434,783 shares were issued which were authorized as of December 31, 2018. A gain on extinguishment of debt of $159,233, extinguishment of debt discount of $233,571 and reduction of derivative liabilities of $940,382 have been recorded related to these conversions. As of December 31, 2019, 35,844 shares, valued at $35,844 for debt conversion were authorized, but not issued as of December 31, 2019. We issued 4,987,610 shares of common stock, valued at $170,348, for services. As December 31, 2019, 209,782 shares, valued at $11,598 for services were authorized, but not issued as of December 31, 2019, and included in stock to be issued in the accompanying consolidated balance sheet. In connection with Debt Restructure Agreements dated on July 17, 2018, 675,759 shares of common stock were cancelled, valued at $108,121. We issued 24,566,400 shares of common stock, valued at $732,029, for related party services. As December 31, 2019, 3,299,665 shares, valued at $79,817 for services, were authorized but not issued as of December 31, 2019. During the year ended December 31, 2019, 8,071,000 shares were issued for cashless warrant exercise. During the year ended December 31, 2019, we issued 5,000 shares for $2,648, which were authorized in prior period. Common stock warrant activity: The Company has determined that certain of its warrants are subject to derivative accounting. The table below provides a reconciliation of the beginning and ending balances for the warrant liabilities measured using fair significant unobservable inputs (Level 3) for the years ended December 31, 2020 and 2019: Year ended December 31, 2020 2019 Balance at beginning of year $ 967 $ 16,576 Additions to derivative instruments — — Loss (gain) on change in fair value of derivative liability (491 ) (15,609 ) Balance at end of year $ 476 $ 967 The following assumptions were used in the Binomial Option Pricing Model in calculating the embedded conversion features and current liabilities for the years ended December 31, 2020 and 2019: December 31, 2020 December 31, 2019 Annual dividend yield 0 % 0 % Expected life (years) 0.42 – 7.38 0.42 – 8.13 Risk-free interest rate 0.10 – 1.83 % 1.56 – 2.40 % Expected volatility 186 - 240 % 165 - 318 % The following table summarizes stock warrant activity for the years ended December 31, 2020 and 2019: Number of Weighted- Weighted- Outstanding at December 31, 2018 263,866 $ 12.04 Granted — $ — Exercised (12,500 ) 2.95 Expired (39,540 ) $ 20.00 Outstanding at December 31, 2019 211,826 $ 10.08 3.5 Granted — $ — Expired (78,031 ) $ 18.72 Outstanding at December 31, 2020 133,795 $ 5.04 4.4 Exercisable at December 31, 2020 133,795 $ 5.04 4.4 Common stock option activity: The Company maintains an Equity Incentive Plan pursuant of which 124,000 shares of Common Stock are reserved for issuance thereunder. This Plan was established to award certain founding members, who were instrumental in the development of the Company, as well as key employees, directors and consultants, and to promote the success of the Company’s business. The terms allow for each option to vest immediately, with a term no greater than 10 years from the date of grant, at an exercise price equal to par value at date of the grant. As of December 31, 2020, 88,750 shares had been granted, with 10,000 of those shares granted with warrants attached. There remain 35,250 shares available for future grants. During the years ended December 31, 2020 and 2019, the Company recorded total option expense of $86,606 and $162,381, respectively. There was no unamortized stock option expense at December 31, 2020. The aggregate intrinsic value of stock options outstanding at December 31, 2020 is $0. The following table summarizes stock option activity for the years ended December 31, 2020 and 2019: Number of Weighted- Weighted- Outstanding at December 31, 2018 294,959 $ 5.17 Granted — $ — Exercised — — Expired (122,480 ) $ 5.00 Outstanding at December 31, 2019 172,479 $ 5.29 5.5 Granted — $ — Forfeited — $ — Outstanding at December 31, 2020 172,479 $ 5.29 4.5 Exercisable at December 31, 2020 172,479 $ 5.29 4.5

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 11 – COMMITMENTS AND CONTINGENCIES Leases The Company leases property under operating leases. Property leases include retail and warehouse space with fixed rent payments and lease terms ranging from three to five years. The Company is obligated to pay the lessor for maintenance, real estate taxes, insurance and other operating expenses on certain property leases. These expenses are variable and are not included in the measurement of the lease asset or lease liability. These expenses are recognized as variable lease expense when incurred. The Company records the lease asset and lease liability at the present value of lease payments over the lease term. The leases typically do not provide an implicit rate; therefore, the Company uses its estimated incremental borrowing rate at the time of lease commencement to discount the present value of lease payments. The Company’s discount rate for operating leases at December 31, 2020 was 12%. Leases often include rental escalation clauses, renewal options and/or termination options that are factored into the determination of lease payments when appropriate. Lease expense is recognized on a straight-line basis over the lease term to the extent that collection is considered probable. As a result the Company been recognizing rents as they become payable. Our weighted-average remaining lease term is 4.24 years. As of December 31, 2020, the maturities of operating leases liabilities are as follows (in thousands): Operating Leases 2021 427 2022 270 2023 270 2024 270 2025 45 Total 1,282 Less: amount representing interest (239 ) Present value of future minimum lease payments 1,043 Less: current obligations under leases 328 Long-term lease obligations $ 715 The Company executed a series of agreements that canceled the master lease on its Elizabeth street cannabis cultivation facility in Denver on October 21, 2020. This has allowed the Company to reduce its liability exposure in the Elizabeth Street cultivation facility while securing deferred rents due and future sublet payments for 3 years and 9 months, valued at $1,325,443 (see Note 5). In addition, a $60,000 deposit on the property has been returned to the Company. Rent expense is recognized on a straight-line basis over the life of the lease. Rent expense consists of the following: Year ended December 31, 2020 2019 Operating lease costs $ 610,374 $ 756,515 Variable rent costs 396,207 432,837 Total rent expense $ 1,006,581 $ 1,189,352 As of December 31, 2020, the aggregate remaining minimal annual lease payments under these operating leases plus NNN were as follows: (in thousands): 2021 $ 328 2022 197 2023 222 2024 250 2025 46 Total $ 1,043 Other information related to leases is as follows: Year ended Other information: Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 606,870 Lease liability related to termination of lease 1,325,445 Weighted-average remaining lease term - operating leases 3.54 yr Weighted-average discount rate - operating leases 12 % The Company recognized sublease income of $1,265,137 and $1,646,369 during the years ended December 31, 2020 and 2019, respectively. These two leases have six months and 4.2 year terms with optional extension, expiration dates range from July 2021 to June 2025, and monthly base rent approximately $22,000-$25,000 plus variable NNN. As of December 31, 2020, the maturities of expected base sublease income are as follows (in thousands): Operating Leases 2021 $ 582 2022 346 2023 346 2024 346 2025 and beyond 58 Total $ 1,678 COVID-19 On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency in response to a new strain of a coronavirus (the “COVID-19 outbreak”). In March 2020, the WHO classified the COVID-19 outbreak as a pandemic based on the rapid increase in exposure globally. The full impact of the COVID-19 outbreak continues to evolve as of the date of this report. Management is actively monitoring the global situation and its effects on the Company’s industry, financial condition, liquidity, and operations. Given the daily evolution of the COVID-19 outbreak and the global responses to curb its spread, the Company is not able to estimate the effects of the COVID-19 outbreak on its results of operations, financial condition, or liquidity for fiscal year 2021. However, if the pandemic continues, it may have a material adverse effect on the Company’s results of future operations, financial position, and liquidity in fiscal year 2021. Employment Agreements As a condition of their employment, the Board of Directors approved employment agreements with three key executives. These agreements provided that additional shares will be granted each year over the term of the agreements should their shares as a percentage of the total shares outstanding fall below prescribed ownership percentages. Nello Gonfiantini III, who became the Company’s CEO in October 2019 receives an annual grant of additional shares each year to maintain his ownership percentage at 10% of the outstanding stock. The Company’s CFO received a similar grant each to maintain his ownership percentage at 2% of the outstanding stock. In addition, prior to his departure in October 2019, Ron Throgmartin, the Company’s previous CEO, would receive a grant of additional shares to maintain his ownership at 7.5% of the Company’s outstanding stock. During the year ended December 31, 2020, the Company accrued compensation expense of approximately $118,000 on 10,935,040 shares of common stock under these agreements. During the year ended December 31, 2019, the Company accrued compensation expense of approximately $593,000 on 20,782,014 shares of common stock under these agreements. As of December 31, 2020 and 2019, the ending balance of accrued compensation was $13,467 and $79,817, respectively. The number of shares accrued to be issued was 1,731,687 at December 31, 2020. Departure of Executive Officer On January 30, 2019, the Company executed a Separation Agreement and Release with David Thompson, its former Senior Vice President- Finance, finalizing his departure from the Company as an employee. Pursuant to its material terms, the Company agreed to pay Mr. Thompson aggregate cash payments of $206,250, based upon the Company’s receipt of certain gross sales receipts derived from its Alameda Store in Colorado, and certain stock grants based upon the Company’s outstanding common shares as of February 1, 2019, including a stock grant of 53,717 restricted common shares for accrued salary and 122,934 restricted common shares in exchange for his approximate 122,000 of stock options. During the years ended December 31, 2020 and 2019, $34,538 and $9,450, respectively, were paid under this agreement. As of December 31, 2020, the outstanding balance was $162,262, and is included in Accrued payable – related party in the accompanying consolidated balance sheet. On October 29, 2019, the Company accepted the resignation of Ron Throgmartin from his positions as CEO, President and Director. Mr. Throgmartin’s resignation was not the result of any disagreements with Registrant’s plan of operations, policies or management. On the same date, we appointed Christopher D. Strachan, our Chief Financial Officer, to membership on our Board of Directors and appointed Nello Gonfiantini III, our Chief Operations Officer, to the additional post of Chief Executive Officer. Ron Throgmartin signed a 5-year term Separation Agreement which, among other matters, terminated his Employment Agreement, as amended. On the date of the Separation Agreement, the Company acknowledged it owed Mr. Throgmartin the amount of $517,252 in principal and accrued interest of note payable, salary and fees, accrued during the 5 years of his employment. In addition, the Corporation further acknowledged that it will pay Mr. Throgmartin fifty (50%) percent of his compensation due under the remaining Employment Agreement, or $614,583 under certain conditions, which the Company accrued in full as the date of Mr. Throgmartin’s separation. This agreement provides that the Registrant will pay him $5,000 monthly against his accrued salary/fees and 50% of future compensation due under his terminated Employment Agreement, with certain accelerated payments in the event Registrant’s financial results attain certain EBITA benchmarks. Registrant shall have the right to require Mr. Throgmartin to provide consulting services to Registrant for a per diem fee of $500. During the years ended December 31, 2020 and 2019, $60,000 and $15,000, respectively, were paid under this agreement. As of December 31, 2020, the outstanding balance was $880,597, and is included in Accrued payable – related party in the accompanying consolidated balance sheet.

Deferred Tax Assets and Income

Deferred Tax Assets and Income Tax Provision	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Deferred Tax Assets and Income Tax Provision	Note 12 – Deferred Tax Assets and Income Tax Provision The reconciliation of income tax benefit at the U.S. statutory rate of 21% for the years ended December 31, 2020 and 2019 respectively to the Company’s effective tax rate is as follows: Year Ended Year Ended December 31, 2020 December 31, 2019 Statutory federal income tax rate (21 )% (21 )% State income tax, net of federal benefits (5 )% (5 )% Change in federal tax rate — % — % Change in valuation allowance 26 % 26 % Income tax provision (benefit) — % — % The benefit for income tax is summarized as follows: Year Ended Year Ended Federal Current $ — $ — Deferred 79,000 479,000 State Current — — Deferred 17,000 105,000 Change in valuation allowance (96,000 ) (584,000 ) Income tax provision (benefit) $ — $ — Deferred tax assets (liabilities) consist of the following: Year Ended Year Ended December 31, December 31, Net operating loss carry forwards $ (6,492,759 ) $ (6,413,626 ) Warrants issued for services 1,467,413 1,417,025 Impairment of investment 111,662 111,662 Depreciation 54,066 101,728 Interest expense on convertible notes 2,688,874 2,140,769 Total gross deferred tax asset/liabilities (2,170,744 ) (2,642,442 ) Valuation allowance 2,170,744 2,642,442 Net deferred taxes $ — $ — As of December 31, 2020, the Company had accumulated Federal net operating loss carryovers (“NOLs”) of $30,917,902. These NOLs can be carried forward indefinitely and the utilization of NOLs may be subject to limitation under the Internal Revenue Code Section 382 should there be a greater than 50% ownership change as determined under the regulations. In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. Based on the assessment, management has established a full valuation allowance against the entire deferred tax asset relating to NOLs for every period because it is more likely than not that all of the deferred tax asset will not be realized. The Company files U.S. Federal and various State tax returns that are subject to audit by tax authorities beginning with the year ended December 31, 2017. The Company’s policy is to classify assessments, if any, for tax and related interest and penalties as tax expense.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	Note 13 – Subsequent Events The Company evaluated subsequent events and transactions that occur after the balance sheet date up to the date that the consolidated financial statements are available to be issued. Any material events that occur between the balance sheet date and the date that the consolidated financial statements were available for issuance are disclosed as subsequent events, while the consolidated financial statements are adjusted to reflect any conditions that existed at the balance sheet date. Based upon this review, except as disclosed within the footnotes or as discussed below, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the consolidated financial statements. During the period from January 1, 2021 through March 31, 2021: The PPP loan described in Note 8 was fully forgiven in February 2021. We issued 5,026,413 shares of common stock upon the conversion of $100,000 principal amount of notes plus $6,256 of accrued interest. We paid $200,000 in principal amount of notes at maturity. We sold 293,700 shares of Series C preferred stock for net proceeds of $260,000. We issued 30,000 shares of common stock for services

Significant and Critical Acco_2

Significant and Critical Accounting Policies and Practices (Policies)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying consolidated financial statements and related notes have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and presented in accordance with accounting principles generally accepted in the United States of America (US GAAP).
Principles of Consolidation	Principles of Consolidation The financial statements include the accounts of Diego Pellicer Worldwide, Inc., and its wholly-owned subsidiary Diego Pellicer World-wide 1, Inc. Intercompany balances and transactions have been eliminated in consolidation.
Reclassifications	Reclassifications $344,761 of other receivable of prior year amounts were reclassified from current assets to long term assets to conform to the manner of presentation in the current period. These reclassifications had no effect on the Company's balance sheet, net loss or stockholders' equity.
Use of Estimates	Use of Estimates The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates. These estimates and assumptions include valuing equity securities and derivative financial instruments issued in financing transactions and share based payment arrangements, the collectability of accounts receivable and other receivables (See Note 5), valuation of right of use assets and lease liabilities and deferred taxes and related valuation allowances. Certain estimates, including evaluating the collectability of accounts receivable, could be affected by external conditions, including those unique to our industry, and general economic conditions. It is possible that these external factors could influence our estimates and could cause actual results to differ from our estimates. The Company intends to re-evaluate all its accounting estimates at least quarterly based on these conditions and record adjustments when necessary.
Fair Value Measurements	Fair Value Measurements The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.
Fair Value of Financial Instruments	Fair Value of Financial Instruments As required by the Fair Value Measurements and Disclosures Topic of the FASB ASC, fair value is measured based on a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2: Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; and Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity). Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of December 31, 2020 and December 31, 2019. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values. These financial instruments include cash, prepaid expenses and accounts payable. Fair values were assumed to approximate carrying values for cash and payables because they are short term in nature and their carrying amounts approximate fair values or they are payable on demand. The following table reflects assets and liabilities that are measured at fair value on a recurring basis (in thousands): As of December 31, 2020 Fair Value Measurement Using Level 1 Level 2 Level 3 Total Derivative liabilities $ — $ — $ 5,998 $ 5,998 Stock warrant liabilities — — 1 1 $ — $ — $ 5,999 $ 5,999 As of December 31, 2019 Fair Value Measurement Using Level 1 Level 2 Level 3 Total Derivative Liabilities $ — $ — $ 5,024 $ 5,024 Stock warrant Liabilities — — 1 1 $ — $ — $ 5,025 $ 5,025 Derivative liabilities and stock warrant liabilities were valued using the Binomial Option Pricing Model in calculating the embedded conversion features for the years ended December 31, 2020 and 2019.
Cash	Cash The Company maintains cash balances at various financial institutions. Accounts at each institution are insured by the Federal Deposit Insurance Corporation, and the National Credit Union Share Insurance Fund, up to $250,000. The Company’s accounts at these institutions may, at times, exceed the federal insured limits. The Company has not experienced any losses in such accounts. Uninsured balances were approximately $73,000 and $63,000 at December 31, 2020 and 2019, respectively.
Revenue Recognition	Revenue recognition In accordance with ASC 842, Leases, During the initial term of the lease, management has a policy of partial rent forbearance when the tenant first opens the facility to assure that the tenant has the opportunity for success. Management may be required to exercise considerable judgment in estimating revenue to be recognized. When management concludes that the Company is the owner of tenant improvements, the Company records the cost to construct the tenant improvements as a capital asset. In addition, the Company records the cost of certain tenant improvements paid for or reimbursed by tenants as capital assets when management concludes that the Company is the owner of such tenant improvements. For these tenant improvements, the Company records the amount funded or reimbursed by tenants as deferred revenue, which is amortized as additional rental income over the term of the related lease. When management concludes that the tenant is the owner of tenant improvements for accounting purposes, we record the Company’s contribution towards those improvements as a lease incentive, which is amortized as a reduction to rental revenue on a straight-line basis over the term of the lease. The Company has adopted the new revenue recognition guidelines in accordance with ASC 606, Revenue from Contracts with Customers (ASC 606), commencing from January 1, 2019. The adoption of ASC 606 did not have a material impact on the financial statements and related disclosures since the Company is primarily a lessor for revenue purposes and recognizes rent income under ASC 842, Leases The Company analyzes its contracts to assess that they are within the scope and in accordance with ASC 606. In determining the appropriate amount of revenue to be recognized as the Company fulfills its obligations under each of its agreements, whether for goods and services or licensing, the Company performs the following steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations based on estimated selling prices; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.
Advertising	Advertising During the years ended December 31, 2020 and 2019, advertising expense was $32,940 and $52,605, respectively.
Income Taxes	Income Taxes Income taxes are provided for using the liability method of accounting in accordance with the Income Taxes Topic of the FASB ASC. Deferred tax assets and liabilities are determined based on differences between the financial reporting and tax basis of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is established when necessary to reduce deferred tax assets to the amount expected to be realized and when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The computation of limitations relating to the amount of such tax assets, and the determination of appropriate valuation allowances relating to the realizing of such assets, are inherently complex and require the exercise of judgment. As additional information becomes available, the Company continually assesses the carrying value of their net deferred tax assets.
Common Stock Purchase Warrants and Other Derivative Financial Instruments	Common Stock Purchase Warrants and Other Derivative Financial Instruments The Company classifies as equity any contracts that require physical settlement or net-share settlement or provide us a choice of net cash settlement or settlement in our own shares (physical settlement or net-share settlement) provided that such contracts are indexed to our own stock as defined in ASC Topic 815-40 “Contracts in Entity’s Own Equity.” The Company classifies as assets or liabilities any contracts that require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside our control or give the counterparty a choice of net-cash settlement or settlement in shares. The Company assesses classification of its common stock purchase warrants and other free-standing derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required.
Stock-Based Compensation	Stock-Based Compensation The Company recognizes compensation expense for stock-based compensation in accordance with ASC Topic 718. The Company calculates the fair value of the award on the date of grant using the Black-Scholes method for stock options and the quoted price of our common stock for common shares; the expense is recognized over the service period for awards expected to vest. The estimation of stock-based awards that will ultimately vest requires judgment, and to the extent actual results or updated estimates differ from original estimates, such amounts are recorded as a cumulative adjustment in the period estimates are revised. The Company considers many factors when estimating expected forfeitures, including types of awards, employee class, and historical experience.
Income (loss) per common share	Income (loss) per common share The Company utilizes ASC 260, “Earnings per Share” for calculating the basic and diluted loss per share. In accordance with ASC 260, the basic and diluted loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding. Diluted net loss per share is computed similar to basic loss per share except that the denominator is adjusted for the potential dilution that could occur if stock options, warrants, and other convertible securities were exercised or converted into common stock. Potentially dilutive securities are not included in the calculation of the diluted loss per share if their effect would be anti-dilutive. The Company has 1,462,069,888 and 631,737,597 common stock equivalents at December 31, 2020 and 2019, respectively. For the years ended December 31, 2020 and 2019, these potential shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would reduce net loss per share. There are 840,000,000 shares authorized resulting in 839,341,383 insufficient shares as of December 31, 2020.
Legal and Regulatory Environment	Legal and regulatory environment The cannabis industry is subject to numerous laws and regulations of federal, state and local governments. These laws and regulations include, but are not limited to, matters such as licensure, accreditation, and different taxation between federal and state. Federal government activity may increase in the future with respect to companies involved in the cannabis industry concerning possible violations of federal statutes and regulations. Management believes that the Company is in compliance with local, state and federal regulations and, while no regulatory inquiries have been made, compliance with such laws and regulations can be subject to future government review and interpretation, as well as regulatory actions unknown or unasserted at this time.
Recent accounting pronouncements	Recent accounting pronouncements. The Company believes recently issued accounting pronouncements and other authoritative guidance for which the effective date is in the future either will not have an impact on its accounting or reporting or that such impact will not be material to its financial position, results of operations and cash flows when implemented.

Organization and Operations (Ta

Organization and Operations (Tables)	12 Months Ended
	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of properties generating rents	The properties generating rents in 2020 and 2019 are as follows: Purpose Size City State Retail store (recreational and medical) 3,300 sq. Denver CO Cultivation warehouse – terminated October 2020 18,600 sq. Denver CO Cultivation warehouse 14,800 sq. Denver CO Retail store (recreational and medical) – sold in May 2019 4,500 sq. Seattle WA

Significant and Critical Acco_3

Significant and Critical Accounting Policies and Practices (Tables)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Schedule of fair value, assets and liabilities measured on recurring basis	The following table reflects assets and liabilities that are measured at fair value on a recurring basis (in thousands): As of December 31, 2020 Fair Value Measurement Using Level 1 Level 2 Level 3 Total Derivative liabilities $ — $ — $ 5,998 $ 5,998 Stock warrant liabilities — — 1 1 $ — $ — $ 5,999 $ 5,999 As of December 31, 2019 Fair Value Measurement Using Level 1 Level 2 Level 3 Total Derivative Liabilities $ — $ — $ 5,024 $ 5,024 Stock warrant Liabilities — — 1 1 $ — $ — $ 5,025 $ 5,025

Accounts Receivables and Othe_2

Accounts Receivables and Other Receivables (Tables)	12 Months Ended
	Dec. 31, 2020
Common shares issued for security payment of convertible notes, value
Schedule of monthly payments accrued	RAM shall continue to accrue debt to the company, assessed on the first day of each month, according to the schedule below: Monthly Payments Accrued October 1, 2020 to June 30, 2021 $ 11,284 July 1, 2021 to June 30, 2022 11,622 July 1, 2022 to June 30, 2023 11,971 July 1, 2023 to June 30, 2024 12,330

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	12 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Schedule of Liabilities Measured Using Fair Significant Unobservable Inputs (Level 3)	The table below provides the note payable activity for the years ended December 31, 2020 and 2019, and also a reconciliation of the beginning and ending balances for the derivative liabilities measured using fair significant unobservable inputs (Level 3) for the years ended December 31, 2020 and 2019: Convertible Discount Convertible Derivative Balance, December 31, 2019 $ 3,266,775 $ 914,245 $ 2,352,530 $ 4,834,190 Issuance of convertible notes 103,000 103,000 — 518,678 Extensions of convertible notes 100,000 — 100,000 149,500 Conversion of convertible notes (180,922 ) (53,567 ) (127,355 ) (177,037 ) Repayment of convertible notes (49,579 ) (21,075 ) (28,504 ) (28,930 ) Change in fair value of derivatives — — — 701,464 Amortization — (942,603 ) 942,603 — Balance December 31, 2020 $ 3,239,274 $ — $ 3,239,274 $ 5,997,865 Convertible Discount Convertible Derivative Balance, December 31, 2018 $ 3,324,487 $ 2,151,168 $ 1,173,319 $ 6,000,830 Issuance of convertible notes 905,500 905,500 — 1,803,495 Conversion of convertible notes (842,712 ) (233,571 ) (609,141 ) (940,382 ) Repayment of convertible notes (120,500 ) (3,659 ) (116,841 ) (56,197 ) Change in fair value of derivatives — — — (1,973,556 ) Amortization — (1,905,193 ) 1,905,193 — Balance December 31, 2019 $ 3,266,775 $ 914,245 $ 2,352,530 $ 4,834,190
Schedule of Assumptions Used Black Scholes Model	The following assumptions were used in the Binomial Option Pricing Model in calculating the embedded conversion features and current liabilities for the years ended December 31, 2020 and 2019: December 31, December 31, Risk-free interest rates 0.08 % 1.53 – 2.60 % Expected life (years) 0.25 0.08 – 1.25 Expected dividends 0 % 0 % Expected volatility 164 % 70-557 %

Stockholder's Equity (Deficit)

Stockholder's Equity (Deficit) (Tables)	12 Months Ended
	Dec. 31, 2020
Equity [Abstract]
Schedule of temporary equity	The Series C Preferred Stock was classified as temporary equity due to that the shares are immediately convertible at the option of the note holder. Preferred Discount Preferred Derivative Balance , January 1, 2019 $ — — — — Issuance of Series C Preferred shares 140,000 140,000 — 165,218 Accretion of discount — (8,750 ) 8,750 — Change in fair value of derivatives — — — 24,913 Balance, December 31, 2019 140,000 131,250 8,750 190,131 Issuance of Series C Preferred shares 111,600 111,600 — 170,896 Conversion of Series C Preferred shares and accrued dividend (265,115 ) (175,820 ) (89,295 ) (353,005 ) Accretion of conversion feature on Series C preferred stock 13,515 (67,030 ) 80,545 23,290 Change in fair value of derivatives — — — (31,312 ) Balance December 31, 2020 $ — $ — $ — $ —
Schedule of assumptions	The following assumptions were used in the Binomial Option Pricing Model in calculating the embedded conversion features and current liabilities for the years ended December 31, 2020 and 2019: 2020 2019 Risk-free interest rates 0.11 – 0.23% 1.58 – 1.66% Expected life (years) 1.5 – 2.0 1.95 – 2.0 Expected dividends 0% 0% Expected volatility 172 – 262% 248 - 250%
Schedule of Warrant Liabilities Measured using Fair Significant Unobservable Inputs (Level 3)	The table below provides a reconciliation of the beginning and ending balances for the warrant liabilities measured using fair significant unobservable inputs (Level 3) for the years ended December 31, 2020 and 2019: Year ended December 31, 2020 2019 Balance at beginning of year $ 967 $ 16,576 Additions to derivative instruments — — Loss (gain) on change in fair value of derivative liability (491 ) (15,609 ) Balance at end of year $ 476 $ 967
Schedule of Fair Value on Assumptions	The following assumptions were used in the Binomial Option Pricing Model in calculating the embedded conversion features and current liabilities for the years ended December 31, 2020 and 2019: December 31, 2020 December 31, 2019 Annual dividend yield 0 % 0 % Expected life (years) 0.42 – 7.38 0.42 – 8.13 Risk-free interest rate 0.10 – 1.83 % 1.56 – 2.40 % Expected volatility 186 - 240 % 165 - 318 %
Schedule of stock warrant activity	The following table summarizes stock warrant activity for the years ended December 31, 2020 and 2019: Number of Weighted- Weighted- Outstanding at December 31, 2018 263,866 $ 12.04 Granted — $ — Exercised (12,500 ) 2.95 Expired (39,540 ) $ 20.00 Outstanding at December 31, 2019 211,826 $ 10.08 3.5 Granted — $ — Expired (78,031 ) $ 18.72 Outstanding at December 31, 2020 133,795 $ 5.04 4.4 Exercisable at December 31, 2020 133,795 $ 5.04 4.4
Schedule of Stock Option Activity	The following table summarizes stock option activity for the years ended December 31, 2020 and 2019: Number of Weighted- Weighted- Outstanding at December 31, 2018 294,959 $ 5.17 Granted — $ — Exercised — — Expired (122,480 ) $ 5.00 Outstanding at December 31, 2019 172,479 $ 5.29 5.5 Granted — $ — Forfeited — $ — Outstanding at December 31, 2020 172,479 $ 5.29 4.5 Exercisable at December 31, 2020 172,479 $ 5.29 4.5

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Schedule of maturities of operating leases liabilities	As of December 31, 2020, the maturities of operating leases liabilities are as follows (in thousands): Operating Leases 2021 427 2022 270 2023 270 2024 270 2025 45 Total 1,282 Less: amount representing interest (239 ) Present value of future minimum lease payments 1,043 Less: current obligations under leases 328 Long-term lease obligations $ 715
Schedule of rent expense is recognized on a straight-line basis	Rent expense is recognized on a straight-line basis over the life of the lease. Rent expense consists of the following: Year ended December 31, 2020 2019 Operating lease costs $ 610,374 $ 756,515 Variable rent costs 396,207 432,837 Total rent expense $ 1,006,581 $ 1,189,352
Schedule of cash flows of operating leases over the next five years	As of December 31, 2020, the aggregate remaining minimal annual lease payments under these operating leases plus NNN were as follows: (in thousands): 2021 $ 328 2022 197 2023 222 2024 250 2025 46 Total $ 1,043
Schedule of other information related to leases	Other information related to leases is as follows: Year ended Other information: Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 606,870 Lease liability related to termination of lease 1,325,445 Weighted-average remaining lease term - operating leases 3.54 yr Weighted-average discount rate - operating leases 12 %
Sublease income	As of December 31, 2020, the maturities of expected base sublease income are as follows (in thousands): Operating Leases 2021 $ 582 2022 346 2023 346 2024 346 2025 and beyond 58 Total $ 1,678

Deferred Tax Assets and Incom_2

Deferred Tax Assets and Income Tax Provision (Tables)	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Schedule of Reconciliation of Effective Income Tax Benefit Rate	The reconciliation of income tax benefit at the U.S. statutory rate of 21% for the years ended December 31, 2020 and 2019 respectively to the Company’s effective tax rate is as follows: Year Ended Year Ended December 31, 2020 December 31, 2019 Statutory federal income tax rate (21 )% (21 )% State income tax, net of federal benefits (5 )% (5 )% Change in federal tax rate — % — % Change in valuation allowance 26 % 26 % Income tax provision (benefit) — % — %
Schedule of Income Tax Benefit	The benefit for income tax is summarized as follows: Year Ended Year Ended Federal Current $ — $ — Deferred 79,000 479,000 State Current — — Deferred 17,000 105,000 Change in valuation allowance (96,000 ) (584,000 ) Income tax provision (benefit) $ — $ —
Schedule of Deferred Tax Assets	Deferred tax assets (liabilities) consist of the following: Year Ended Year Ended December 31, December 31, Net operating loss carry forwards $ (6,492,759 ) $ (6,413,626 ) Warrants issued for services 1,467,413 1,417,025 Impairment of investment 111,662 111,662 Depreciation 54,066 101,728 Interest expense on convertible notes 2,688,874 2,140,769 Total gross deferred tax asset/liabilities (2,170,744 ) (2,642,442 ) Valuation allowance 2,170,744 2,642,442 Net deferred taxes $ — $ —

Organization and Operations (De

Organization and Operations (Details)	12 Months Ended
	Dec. 31, 2020ft²
State	DE
Retail store (recreational and medical)
Area	3,300
City	Denver
State	CO
Cultivation warehouse
Area	18,600
City	Denver
State	CO
Cultivation warehouse
Area	14,800
City	Denver
State	CO
Retail store (recreational and medical) - sold
Area	4,500
City	Seattle
State	WA

Organization and Operations (_2

Organization and Operations (Details Narrative)	May 06, 2019USD ($)	Oct. 31, 2020ft²
Proceeds from seattle property | $	$ 550,000
Cultivation warehouse
Area terminated | ft²		18,600

Significant and Critical Acco_4

Significant and Critical Accounting Policies and Practices (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Derivative liabilities	$ 5,998	$ 5,024
Stock warrant liabilities	1	1
Total	5,999	5,025
Level 1 [Member]
Derivative liabilities
Stock warrant liabilities
Total
Level 2 [Member]
Derivative liabilities
Stock warrant liabilities
Total
Level 3 [Member]
Derivative liabilities	5,998	5,024
Stock warrant liabilities	1	1
Total	$ 5,999	$ 5,025

Significant and Critical Acco_5

Significant and Critical Accounting Policies and Practices (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Uninsured balances	$ 73,000	$ 63,000
Common stock equivalents	1,462,069,888	631,737,597
Advertising expense	$ 32,940	$ 52,605
Shares authorized	840,000,000	840,000,000
Insufficient shares	839,341,383
Maximum [Member]
Cash insured by FDIC	$ 250,000

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Working capital deficit	$ (11,767,522)
Accumulated deficit	$ (55,110,000)	$ (51,968,902)

Property and Equipment (Details

Property and Equipment (Details Narrative) - USD ($)	May 06, 2019	Dec. 31, 2020	Dec. 31, 2019
Property, Plant and Equipment [Abstract]
Sale of seattle leased location	$ 550,000
Amortized of leasehold improvements	$ 566,830
Depreciation expense			$ 139,595

Accounts Receivables and Othe_3

Accounts Receivables and Other Receivables (Details)	Dec. 31, 2020USD ($)
Monthly Payments Accrued
October 1, 2020 to June 30, 2021	$ 11,284
July 1, 2021 to June 30, 2022	11,622
July 1, 2022 to June 30, 2023	11,971
July 1, 2023 to June 30, 2024	$ 12,330

Accounts Receivables and Othe_4

Accounts Receivables and Other Receivables (Details Narrative)	Sep. 09, 2020USD ($)	Apr. 02, 2018	Feb. 27, 2020USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Oct. 31, 2020USD ($)ft²	Jul. 25, 2018USD ($)
Notes receivable				$ 1,030,422	$ 788,177
Accrued interest receivable				300,422	153,509
Leasing hold improvement paid				228,966	228,966
Receivables guaranteed				400,000
Other receivables				1,030,422	788,177
Receivables from subleases				523,958	391,273
Interest income				146,913	153,509
Advances from related party				254,448
Proceeds from related party				388,082
Principal amount							$ 400,000
Long term notes receivable				1,482,824
Lease Termination Payments				$ 33,851
Maturity date		Oct. 31, 2018		Jun. 30, 2024
Accrued interest receivable				$ 300,000
Cultivation warehouse
Area terminated | ft²						18,600
Membership Interest Purchase Agreement [Member]
Ownership percentage	15.13%
Minimum [Member]
Interest rate				12.00%
Maximum [Member]
Interest rate				18.00%
RAM [Member]
Debt of deferred rent						$ 1,418,480
Revenues				$ 725,000
VPC [Member]
Debt of deferred rent						$ 64,344
Third Parties [Member]
Other Receivables				$ 1,030,000
E2T2, LLC [Member] | Membership Interest Purchase Agreement [Member]
Proceeds from receivables	$ 300,000		$ 50,000
Payment to related party debt			$ 34,265

Other Assets (Details Narrative

Other Assets (Details Narrative) - USD ($)	May 06, 2019	Dec. 31, 2020	Dec. 31, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Security deposits		$ 90,000	$ 150,000
Settlement of security deposit	$ 20,000
Refund of security deposit		$ 60,000

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Jul. 25, 2018
Accrued fees - related parties	$ 289,897	$ 155,841
Accrued payable	1,042,859	1,137,397
Cash based compensation - related parties	360,000	507,430
Share based compensation - related parties	192,474	894,408
Accrued interest	70,101	63,413
Debt instrument face amount			$ 400,000
Notes payable related parties	$ 140,958	140,958
Related party description	From 2017 to 2019, Mr. Gonfiantini, CEO, personally and through his Company, Crystal Bay Financial LLC, loaned an aggregate amount of $1,020,000 to Royal Asset Management. These notes accrue interest at 17%-18% per annum, and require monthly payment approximately from $5,000 to $20,000. These notes are personally guaranteed by the managing member of Royal Asset Management, and are secured by certain equipment and other tangible properties of Royal Asset Management. Among these notes, $500,000 note was also secured by the medical marijuana licenses held by Royal Asset Management.
Mr. Throgmartin [Member]
Accrued interest	$ 49,401	38,124
Debt instrument face amount	$ 140,958	$ 140,958
Debt instrument interest rate	8.00%

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)	Apr. 02, 2018	Jul. 02, 2020	Jun. 30, 2020	Apr. 22, 2020	Dec. 31, 2020	Dec. 31, 2019	Jul. 25, 2018	Aug. 31, 2015
Note payable principal amount							$ 400,000
Note maturity date	Oct. 31, 2018				Jun. 30, 2024
Note payable					$ 133,403	$ 133,403
Accrued interest					$ 70,101	$ 63,413
Numerica Credit Union [Member]
Proceeds from loan				$ 56,444
Interest rate				1.00%
Small Business Association [Member]
Proceeds from loan		$ 149,900	$ 150,000
Interest rate		3.75%
Third Parties [Member]
Note payable principal amount								$ 126,000

Convertible Notes Payable (Deta

Convertible Notes Payable (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Issuance of convertible notes	$ 100,000	$ 897,725
Repayment of convertible notes	(49,578)	(120,500)
Convertible Notes [Member]
Balance, beginning	3,266,775	3,324,487
Issuance of convertible notes	103,000	905,500
Extensions of convertible notes	100,000
Conversion of convertible notes	(180,922)	(842,712)
Repayment of convertible notes	(49,579)	(120,500)
Change in fair value of derivatives
Amortization
Balance, ending	3,239,274	3,266,775
Discount [Member]
Balance, beginning	914,245	2,151,168
Issuance of convertible notes	103,000	905,500
Extensions of convertible notes
Conversion of convertible notes	(53,567)	(233,571)
Repayment of convertible notes	(21,075)	(3,659)
Change in fair value of derivatives
Amortization	(942,603)	(1,905,193)
Balance, ending		914,245
Convertible Note Net of Discount [Member]
Balance, beginning	2,352,530	1,173,319
Issuance of convertible notes
Extensions of convertible notes	100,000
Conversion of convertible notes	(127,355)	(609,141)
Repayment of convertible notes	(28,504)	(116,841)
Change in fair value of derivatives
Amortization	942,603	1,905,193
Balance, ending	3,239,274	2,352,530
Derivative Liabilities [Member]
Balance, beginning	4,834,190	6,000,830
Issuance of convertible notes	518,678	1,803,495
Extensions of convertible notes	149,500
Conversion of convertible notes	(177,037)	(940,382)
Repayment of convertible notes	(28,930)	(56,197)
Change in fair value of derivatives	701,464	(1,973,556)
Amortization
Balance, ending	$ 5,997,865	$ 4,834,190

Convertible Notes Payable (De_2

Convertible Notes Payable (Details 1)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Risk Free Interest Rates [Member]
Fair value assumptions, percentage	0.08%
Risk Free Interest Rates [Member] | Minimum [Member]
Fair value assumptions, percentage		1.53%
Risk Free Interest Rates [Member] | Maximum [Member]
Fair value assumptions, percentage		2.60%
Expected Life [Member]
Fair value assumptions, term	2 months 30 days
Expected Life [Member] | Minimum [Member]
Fair value assumptions, term		29 days
Expected Life [Member] | Maximum [Member]
Fair value assumptions, term		1 year 2 months 30 days
Expected Dividends [Member]
Fair value assumptions, percentage	0.00%	0.00%
Expected Volatility [Member]
Fair value assumptions, percentage	164.00%
Expected Volatility [Member] | Minimum [Member]
Fair value assumptions, percentage		70.00%
Expected Volatility [Member] | Maximum [Member]
Fair value assumptions, percentage		557.00%

Convertible Notes Payable (De_3

Convertible Notes Payable (Details Narrative) - USD ($)	1 Months Ended		12 Months Ended
	Mar. 29, 2019	Jul. 17, 2018	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Jul. 25, 2018
Derivative liability			$ 5,997,865	$ 4,834,190
Common stock Issued			217,271,495	113,926,332
Gain (Loss) on extinguishment of debt			$ (9,387)	$ 218,196
Principal amount						$ 400,000
Proceeds from convertible notes			100,000	897,725
Black Sholes Merton Option Model [Member]
Loan				700,000
Proceeds from loan	$ 100,000			380,000
Fair value of embedded conversion feature	$ 154,861			586,710
Financing costs				206,710
Debt discount				380,000
Equity and Debt Restructure Agreement [Member] | Investors [Member]
Number of restricted common shares cancelled		2,774,093
Fair value of restricted common shares		$ 443,855
Fair value of embedded conversion feature		3,555,888
Equity and Debt Restructure Agreement [Member] | Second Investors [Member]
Principal amount		545,607
Equity and Debt Restructure Agreement [Member] | First Investors [Member]
Principal amount		1,683,558
Loan		700,000
Proceeds from loan		$ 220,000
Holder [Member]
Convertible notes				842,712
Conversion of convertible notes			180,922	842,712
Accrued interest			$ 14,702	$ 60,627
Debt instruments conversion into shares			39,489,099	48,684,667
Debt Conversion, Converted Instrument, Amount			$ 328,887
Common stock Issued				434,783
Gain (Loss) on extinguishment of debt				$ 159,233
Convertible notes past due			2,839,274
Repayment of debt				120,500
Accrued interest repaid				14,195
Extinguishment of debt discount			53,567	233,571
Reduction of derivative liabilities			180,995	940,382
Convertible debt				$ 905,500
Holder [Member]
Gain (Loss) on extinguishment of debt			3,925
Repayment of debt			7,500
Accrued interest repaid			819
Proceeds from convertible notes			$ 100,000
Minimum [Member]
Interest rate			8.00%
Maximum [Member]
Interest rate			12.00%
Several Convertible Notes [Member]
Financing costs					$ 2,892,033
Debt discount					$ 2,449,275
Several Convertible Notes [Member] | Minimum [Member]
Interest rate				10.00%
Several Convertible Notes [Member] | Maximum [Member]
Interest rate				12.00%
Convertible Notes [Member]
Derivative liability			$ 51,703
Convertible notes			103,000
Conversion of convertible notes			60,922
Accrued interest			$ 1,884
Debt instruments conversion into shares			14,079,305
Debt Conversion, Converted Instrument, Amount			$ 98,080
Interest rate			12.00%
Gain (Loss) on extinguishment of debt			$ (11,761)
Extinguishment of debt discount			28,190
Reduction of derivative liabilities			55,669
Convertible debt			42,078
Convertible Notes 1 [Member]
Accrued interest			6,736
Gain (Loss) on extinguishment of debt			(21,460)
Repayment of debt			67,750
Extinguishment of debt discount			21,075
Reduction of derivative liabilities			18,551
Convertible Notes 2 [Member]
Conversion of convertible notes			120,000
Accrued interest			$ 12,818
Debt instruments conversion into shares			25,409,794
Debt Conversion, Converted Instrument, Amount			$ 230,807
Gain (Loss) on extinguishment of debt			1,968
Extinguishment of debt discount			25,377
Reduction of derivative liabilities			$ 125,334

Stockholder's Equity (Deficit_2

Stockholder's Equity (Deficit) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Accretion of conversion feature on Series C preferred stock	$ (80,545)	$ (8,750)
Preferred Stock and Accrued Dividends [Member]
Balance at beginning	140,000
Issuance of Series C Preferred shares	111,600	140,000
Accretion of discount
Conversion of Series C Preferred shares and accrued dividend	(265,115)
Accretion of conversion feature on Series C preferred stock	13,515
Change in fair value of derivatives
Balance at end		140,000
Preferred Stock and Accrued Dividends Net of Discount [Member]
Balance at beginning	8,750
Issuance of Series C Preferred shares
Accretion of discount		8,750
Conversion of Series C Preferred shares and accrued dividend	(89,295)
Accretion of conversion feature on Series C preferred stock	80,545
Change in fair value of derivatives
Balance at end		8,750
Discount [Member]
Balance at beginning	131,250
Issuance of Series C Preferred shares	111,600	140,000
Accretion of discount		(8,750)
Conversion of Series C Preferred shares and accrued dividend	(175,820)
Accretion of conversion feature on Series C preferred stock	(67,030)
Change in fair value of derivatives
Balance at end		131,250
Derivative Liabilities [Member]
Balance at beginning	190,131
Issuance of Series C Preferred shares	170,896	165,218
Accretion of discount
Conversion of Series C Preferred shares and accrued dividend	(353,005)
Accretion of conversion feature on Series C preferred stock	23,290
Change in fair value of derivatives	(31,312)	24,913
Balance at end		$ 190,131

Stockholder's Equity (Deficit_3

Stockholder's Equity (Deficit) (Details 1)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Expected dividends	0.00%	0.00%
Minimum [Member]
Risk-free interest rate	0.11%	1.58%
Expected life (years)	1 year 6 months	1 year 11 months 12 days
Expected volatility	172.00%	248.00%
Maximum [Member]
Risk-free interest rate	0.23%	1.66%
Expected life (years)	2 years	2 years
Expected volatility	262.00%	250.00%

Stockholder's Equity (Deficit_4

Stockholder's Equity (Deficit) (Details 2) - Level 3 [Member] - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Balance at beginning	$ 967	$ 16,576
Additions to derivative instruments
Loss (gain) on change in fair value of derivative liability	(491)	(15,609)
Balance at end	$ 476	$ 967

Stockholder's Equity (Deficit_5

Stockholder's Equity (Deficit) (Details 3)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Annual dividend yield	0.00%	0.00%
Minimum [Member]
Expected life (years)	5 months 1 day	5 months 1 day
Risk-free interest rate	0.10%	1.56%
Expected volatility	186.00%	165.00%
Maximum [Member]
Expected life (years)	7 years 4 months 17 days	8 years 1 month 16 days
Risk-free interest rate	1.83%	2.40%
Expected volatility	240.00%	318.00%

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit) (Details 4) - $ / shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Weighted average exercise price, Beginning balance	$ 5.29	$ 5.17
Weighted average exercise price, Granted
Weighted average exercise price, Exercised
Weighted average exercise price, Ending balance	5.29	$ 5.29
Weighted average exercise price, Exercisable ending balance	$ 5.29
Weighted average aemaining contractual term	4 years 6 months	5 years 6 months
Weighted average aemaining contractual term, Exercisable ending balance	4 years 6 months
Warrant [Member]
Number of shares, Beginning balance	211,826	263,866
Number of shares, Granted
Number of shares, Exercised		(12,500)
Number of shares, Expired	(78,031)	(39,540)
Number of shares, Ending balance	133,795	211,826
Number of shares,Exercisable ending balance	133,795
Weighted average exercise price, Beginning balance	$ 10.08	$ 12.04
Weighted average exercise price, Granted
Weighted average exercise price, Exercised		2.95
Weighted average exercise price, Expired	18.72	20
Weighted average exercise price, Ending balance	5.04	$ 10.08
Weighted average exercise price, Exercisable ending balance	$ 5.04
Weighted average aemaining contractual term	4 years 4 months 24 days	3 years 6 months
Weighted average aemaining contractual term, Exercisable ending balance	4 years 4 months 24 days

Stockholders' Equity (Deficit_2

Stockholders' Equity (Deficit) (Details 5) - $ / shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Equity [Abstract]
Number of shares, Beginning balance	172,479	294,959
Number of shares, Granted
Number of shares, Exercised
Number of shares, Expired		(122,480)
Number of shares, Forfeited
Number of shares, Ending balance	172,479	172,479
Number of shares, Exercisable ending balance	172,479
Weighted average exercise price, Beginning balance	$ 5.29	$ 5.17
Weighted average exercise price, Granted
Weighted average exercise price, Exercised
Weighted average exercise price, Expired		5
Weighted average exercise price, Forfeited
Weighted average exercise price, Ending balance	5.29	$ 5.29
Weighted average exercise price, Exercisable ending balance	$ 5.29
Weighted average remaining contractual term	4 years 6 months	5 years 6 months
Weighted average remaining contractual term, Exercisable ending balance	4 years 6 months

Stockholder's Equity (Deficit_6

Stockholder's Equity (Deficit) (Details Narrative) - USD ($)	Apr. 14, 2020	Feb. 01, 2019	Dec. 31, 2020	Dec. 31, 2019
Derivative liability			$ 5,998	$ 5,024
Sale of stock				5,000
Common stock issued			217,271,495	113,926,332
Common Stock payable issued for services - related parties			$ 117,887
Common Stock payable issued for services - related parties, shares			10,935,040
Additionally shares reversed			$ 6,914
Additionally shares reversed, shares			283,182
Unissued shares for related party, shares			1,731,687	3,299,665
Unissued shares for related party, value			$ 13,467	$ 79,817
Number of common stock issued for services, shares			12,219,836	4,987,610
Number of common stock issued for services, value			$ 177,323	$ 170,348
Common stock issued for accrued for services, shares			905,658
Common stock issued for accrued for services, value			$ 8,003
Common stock issued for accrued for services reserved, shares			9,583
Common stock issued for accrued for services reserved, value			$ 5,601
Number of shares to be issued for services, shares			1,105,857	209,782
Number of shares to be issued for services, value			$ 14,000	$ 11,598
Common Stock issued for notes payable, shares			3,884
Common Stock issued for notes payable, value			$ 13,983
Number of shares to be issued for debt conversions, shares			31,960	35,844
Number of shares to be issued for debt conversions, Value			$ 21,861	$ 35,844
Common stock issued for legal services, shares			4,000,000
Common stock issued for legal services, value			$ 51,200
Additionally Shares authorized for services but not issued, shares				209,782
Additionally Shares authorized for services but not issued, value				$ 11,598
Stock issued for cashless warrant exercise				8,071,000
Shares available for future grants			114,000
Common stock cancelled				675,759
Common stock cancelled, value				$ 108,121
Stock option expenses			$ 86,606	$ 162,381
Unamortized stock option			0
Number of common stock sold				5,000
Proceeds from sale of common stock				$ 2,648
Intrinsic value of stock options outstanding			$ 0
Reserved for issuance			124,000
Redeemable convertible preferred stock, Series C [Member]
Preferred stock, shares outstanding			0	140,000
Derivative liability			$ 88,868	$ 165,218
Conversion feature			75,652	190,131
Accretion of discount			$ 9,096	$ 8,750
Preferred stock, converted shares			140,000
Debt converted into share			21,744,479
Number of common stock converted			55,800
Number of stock issued			251,600
Geneva [Member] | Series C Convertible Preferred Shares [Member]
Preferred stock, converted shares			55,800
Debt converted into share			15,292,885
Geneva [Member] | Series C Convertible Preferred Shares [Member]
Preferred stock, converted shares			55,800
Debt converted into share			10,598,864
Geneva [Member] | Redeemable convertible preferred stock, Series C [Member]
Preferred stock, shares outstanding			55,800
Cash received from sale of preferred stock			$ 130,000
Designation of Series C shares			1,500,000
Common stock discount percentage			30.00%
Derivative liability			$ 82,028
Accretion of discount			$ 67,201
Sale of stock	55,800
Number of common stock sold	55,800
Number of common stock converted			47,636,228
Debt discount			$ 131,250
Related Party Note [Member]
Stock issued during period, shares, share-based compensation, gross				3,299,665
Stock issued during period, value, share-based compensation				$ 79,817
Number of common stock issued for services, shares				24,566,400
Number of common stock issued for services, value				$ 732,029
Holder [Member]
Number of shares issued for conversion of notes, value			$ 180,922	$ 842,712
Debt converted into share			39,489,099	48,684,667
Accrued interest			$ 14,702	$ 60,627
Debt Conversion, Converted Instrument, Amount			328,887
Extinguishment of debt discount			53,567	233,571
Reduction of derivative liabilities			180,995	$ 940,382
Common stock issued				434,783
Common stock, shares authorized but not issued, shares				35,844
Common stock, shares authorized but not issued, value				$ 35,844
Gain on extinguishment of debt			$ 5,835	$ 159,233
CEO [Member]
Shares granted		122,000

Commitments and Contingencies_2

Commitments and Contingencies (Details)	Dec. 31, 2020USD ($)
Commitments and Contingencies Disclosure [Abstract]
2021	$ 427,000
2022	270,000
2023	270,000
2024	270,000
2025	45,000
Total	1,282,000
Less: amount representing interest	(239,000)
Present value of future minimum lease payments	1,043,000
Less: current obligations under leases	328,000
Long-term lease obligations	$ 715,000

Commitments and Contingencies_3

Commitments and Contingencies (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Operating lease costs	$ 610,374	$ 756,515
Variable rent costs	396,207	432,837
Total rent expense	$ 1,006,581	$ 1,189,352

Commitments and Contingencies_4

Commitments and Contingencies (Details 2)	Dec. 31, 2019USD ($)
Commitments and Contingencies Disclosure [Abstract]
2021	$ 328,000
2022	197,000
2023	222,000
2024	250,000
2024	46,000
Total	$ 1,043,000

Commitments and Contingencies_5

Commitments and Contingencies (Details 3) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 606,870
Lease liability related to termination of lease	$ 1,325,445
Weighted-average remaining lease term - operating leases	3 years 6 months 14 days
Weighted-average discount rate - operating leases	12.00%

Commitments and Contingencies_6

Commitments and Contingencies (Details 4)	Dec. 31, 2020USD ($)
Commitments and Contingencies Disclosure [Abstract]
2021	$ 582,000
2022	346,000
2023	346,000
2024	346,000
2025 and beyond	58,000
Total	$ 1,678,000

Commitments and Contingencies_7

Commitments and Contingencies (Details Narrative) - USD ($)	Feb. 01, 2019	Oct. 29, 2019	Dec. 31, 2020	Dec. 31, 2019
Operating leases discount rate			12.00%
Weighted-average remaining lease term			4 years 2 months 27 days
Sublease income			$ 1,265,137	$ 1,646,369
Stock issued for employment agreements			$ 593,000
Stock issued for employment agreements, Shares			20,782,014
Accrued compensation			$ 13,467	79,817
Accrued compensastion, shares			1,731,687
Proceeds from deposits			$ 60,000
Sublease payment			1,325,443
Outstanding balance			880,597
Refund of security deposit			$ 60,000
Colorado [Member] | Minimum [Member]
Lease term			6 months
Colorado [Member] | Maximum [Member]
Lease term			4 years 2 months 12 days
CEO [Member]
Stock grant for restricted common shares for accrued salary	53,717
Restricted common share issued for stock option	122,934
Stock options issued	122,000
Payment of compensation			$ 34,538	9,450
Accrued compensation			$ 162,262
Employment Agreements [Member] | CEO [Member]
Ownership percentage			10.00%
Employment Agreements [Member] | Other Executives [Member]
Ownership percentage			2.00%
Employment Agreements [Member] | Ron Throgmartin
Term		5 years
Accrued salary		$ 5,000
Diem fee		$ 500
Debt description		Company acknowledged it owed Mr. Throgmartin the amount of $517,252 in principal and accrued interest of note payable, salary and fees, accrued during the 5 years of his employment. In addition, the Corporation further acknowledged that it will pay Mr Throgmartin fifty (50%) percent of his compensation due under the remaining Employment Agreement, or $614,583 under certain conditions
Payment of compensation			$ 60,000	$ 15,000
Accrued compensation			$ 118,000
Accrued compensastion, shares			10,935,040

Deferred Tax Assets and Incom_3

Deferred Tax Assets and Income Tax Provision - Schedule of Reconciliation of Effective Income Tax Benefit Rate (Details)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Statutory federal income tax rate	(21.00%)	(21.00%)
State income tax, net of federal benefits	(5.00%)	(5.00%)
Change in federal tax rate	0.00%	0.00%
Change in valuation allowance	26.00%	26.00%
Income tax provision (benefit)	0.00%	0.00%

Deferred Tax Assets and Incom_4

Deferred Tax Assets and Income Tax Provision - Schedule of Income Tax Benefit (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Federal Current
Federal Deferred	79,000	479,000
State Current
State Deferred	17,000	105,000
Change in valuation allowance	(96,000)	(584,000)
Income tax provision (benefit)

Deferred Tax Assets and Incom_5

Deferred Tax Assets and Income Tax Provision - Schedule of Deferred Tax Assets Liabilities (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Net operating loss carry forwards	$ (6,492,759)	$ (6,413,626)
Warrants issued for services	1,467,413	1,417,025
Impairment of investment	111,662	111,662
Depreciation	54,066	101,728
Interest expense on convertible notes	2,688,874	2,140,769
Total gross deferred tax asset/liabilities	(2,170,744)	(2,642,442)
Valuation allowance	2,170,744	2,642,442
Net deferred taxes

Deferred Tax Assets and Incom_6

Deferred Tax Assets and Income Tax Provision (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Percentage of reconciliation of income tax benefit at U.S. statutory rate	21.00%	21.00%
Federal net operating loss carryovers	$ 30,917,902
Percentage of changes in ownership	50.00%

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - Subsequent Event [Member]	1 Months Ended
	Feb. 28, 2021USD ($)shares
Number of common stock issued | shares	5,026,413
Debt conversion amount	$ 100,000
Debt conversion, accrued interest	6,256
Repayment of debt	$ 200,000
Common stock issued for services, shares | shares	30,000
Redeemable convertible preferred stock, Series C [Member]
Stock sold for cash	$ 260,000
Stock sold for cash, shares | shares	293,700